
HotOct 30, 2026
CelThera™ Stem34 Differentiation Medium AOF was designed against exactly these four gaps. It is chemically defined and animal-origin-free (AOF). It supports the efficient differentiation of PSCs into HSPCs and then continues across the full workflow into NK cells and megakaryocyte/platelet lineages,with potential applications in T cells and other hematopoietic lineages。
Read more
HotJul 22, 2026
With a comprehensive portfolio of GMP-grade cytokines—including E. coli-derived SCF, FLT3L, and TPO—alongside robust quality systems, global supply capabilities, and regulatory support, we are committed to enabling the next generation of HSPC-based cell and gene therapies from discovery to commercialization.
Read more
HotJul 13, 2026
Explore how GMP Activin A and KGF support scalable iPSC-derived islet cell manufacturing for diabetes therapy through efficient definitive endoderm induction, pancreatic progenitor differentiation, and clinical-scale production.
Read moreReceive expert perspectives, research trends, and workflow guidance across emerging therapeutic fields.